In a major clinical study called SELECT, involving more than 17,600 participants, people with heart disease who took semaglutide had about a 20% lower risk of heart attack, stroke, or death from heart disease compared to those who did not take it
Some patients seek its alternatives due to affordability issues, side effects, insufficient results, and the shortage of the medication
Allow flexibility with portion controlled treats to avoid rigid restriction
Very happy with the ease of ordering, how responsive customer service is for any questions, and already noticing a difference in the noise hunger
Its important to remain patient and consistent, as the full benefits of semaglutide are typically realized over a longer period
Available from: Xiao P, Wang H, Liu H, Yuan H, Guo C, Feng Y, et al